Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rebound pain after volar plate surgery: infraclavicular brachial plexus block with ropivacaine 3.75 mg/ml vs 7.5 mg/ml
2024-514795-41-00Phase 4Completed
- Sponsor
- Oslo University Hospital
- Start
- Jan 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, triple-blind trial of ropivacaine in distal forearm fracture (2 arms), sponsored by Oslo University Hospital. Primary endpoint: Worst pain score during the first 48 hours after surgery. Started Jan 2025; status: completed.
02
Drugs
ropivacaine
03
Conditions
distal forearm fracture
Beyond the preview
Go deeper on 2024-514795-41-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514795-41-00.